Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MYOBLOC in Adult Lower Limb Spasticity
NCT04099667Phase 3Terminated
- Sponsor
- MDD US Operations
- Start
- Dec 2019
- Primary completion
- Mar 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 3 trial of botulinum toxin type b in spasticity, sponsored by MDD US Operations. Started Dec 2019; status: terminated.
02
Drugs
botulinum toxin type b
03
Conditions
spasticity
Beyond the preview
Go deeper on NCT04099667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04099667.